Add to ORKGup rot nd as an urothelial cell carcinoma with non-muscle-invasive bladder cancer (NMIBC), but is clinically well controlled number of unnecessary cystoscopy among patients with bladder cancer. Therefore, new pathological and bio-Chung et al. BMC Cancer 2013, 13:4
Background: Cell-cycle proteins are important predictive markers in urothelial carcinoma but may als...
The current personalized oncology era has witnessed significant efforts to integrate clinical, patho...
O F NEW cancer diagnoses each year in the United States, bladder cancer accounts for 4.4%. Excluding...
Approximately 70% to 80% of patients with urothelial carcinomas of the bladder are initially diagnos...
Problem Statement: Transitional Cell Carcinoma (TCC) of the bladder is a significant health problem ...
Urinary bladder cancer is the 11th most common cancer when considering both sexes together and the 7...
Urothelial bladder carcinoma (UBC) is an intricate malignancy with a variable natural history and cl...
International audienceWith 300,000 annually new cases worldwide, urothelial-cell carcinoma of the bl...
Copyright © 2012 Matteo Santoni et al. This is an open access article distributed under the Creative...
Global gene expression pr with that of bladder UC. Our results highlighted both shared (e.g. disorde...
Urothelial cell carcinoma is one of the most common malignancies of the urinary tract. The standard ...
Full list of author information is available at the end of the articleBackground Urothelial carcinom...
Transitional cell carcinoma of the bladder is a common malignancy with an estimated 549 393 new case...
Full list of author information is available at the end of the articleClinically, bladder cancer pos...
Cell locomotion is an essential requirement for invasion and metastasis of malignant cells. We have ...
Background: Cell-cycle proteins are important predictive markers in urothelial carcinoma but may als...
The current personalized oncology era has witnessed significant efforts to integrate clinical, patho...
O F NEW cancer diagnoses each year in the United States, bladder cancer accounts for 4.4%. Excluding...
Approximately 70% to 80% of patients with urothelial carcinomas of the bladder are initially diagnos...
Problem Statement: Transitional Cell Carcinoma (TCC) of the bladder is a significant health problem ...
Urinary bladder cancer is the 11th most common cancer when considering both sexes together and the 7...
Urothelial bladder carcinoma (UBC) is an intricate malignancy with a variable natural history and cl...
International audienceWith 300,000 annually new cases worldwide, urothelial-cell carcinoma of the bl...
Copyright © 2012 Matteo Santoni et al. This is an open access article distributed under the Creative...
Global gene expression pr with that of bladder UC. Our results highlighted both shared (e.g. disorde...
Urothelial cell carcinoma is one of the most common malignancies of the urinary tract. The standard ...
Full list of author information is available at the end of the articleBackground Urothelial carcinom...
Transitional cell carcinoma of the bladder is a common malignancy with an estimated 549 393 new case...
Full list of author information is available at the end of the articleClinically, bladder cancer pos...
Cell locomotion is an essential requirement for invasion and metastasis of malignant cells. We have ...
Background: Cell-cycle proteins are important predictive markers in urothelial carcinoma but may als...
The current personalized oncology era has witnessed significant efforts to integrate clinical, patho...
O F NEW cancer diagnoses each year in the United States, bladder cancer accounts for 4.4%. Excluding...